Cancer drugs become cheaper in India, patients expected to save ₹3,540 crore

According to a report by The Economic Times, the government has significantly reduced the prices of drugs used in cancer treatment. The prices of anti-cancer drugs in the country have been revised, which came into effect from November 9. This decision is expected to provide major financial relief to cancer patients and their families. The government has modified the prices of a total of 1,364 anti-cancer formulations. According to official reports, the main purpose of this step is to limit trade margins and reduce the cost of cancer drugs for consumers.

Due to this price revision, consumers are expected to save ₹3,540.38 crore annually. Considering that patients and their relatives often have to bear a heavy financial burden for the treatment of serious illnesses like cancer, this important decision has been taken. Due to high drug prices, it was extremely difficult for ordinary families to continue treatment, but now with the new rates coming into effect, medicines will become more accessible.

According to the information published by The Economic Times, these revised rates have become effective from November 9. This step by the government will not only control prices but also curb trade margins in the market. Patients will be able to directly derive financial benefits from this, and official reports estimate an annual saving of over ₹3,540 crore. The revised prices of anti-cancer drugs will provide relief to lakhs of patients across the country, and treatments that were previously stalled due to expensive medicines will now become easier.